Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity.

Botros L MD, Pronk MCA PhD, Juschten J MD, Liddle J, Morsing SKSH, van Buul JD PhD, Bates RH, Tuinman PR MD. PhD, van Bezu JSM, Huveneers S PhD, Bogaard HJ MD. PhD, van Hinsbergh VWM PhD, Hordijk PL PhD, Aman J MD. PhD.

J Cell Sci. 2020 Mar 20. pii: jcs.240077. doi: 10.1242/jcs.240077. [Epub ahead of print]

PMID:
32198280
2.

Hematopoietic stem and progenitor cells use podosomes to transcellularly cross the bone marrow endothelium.

Rademakers T, Goedhart M, Hoogenboezem M, García Ponce A, van Rijssel J, Samus M, Schnoor M, Butz S, Huveneers S, Vestweber D, Nolte MA, Voermans C, van Buul JD.

Haematologica. 2020 Jan 23. pii: haematol.2018.196329. doi: 10.3324/haematol.2018.196329. [Epub ahead of print]

3.

DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis.

van der Stoel M, Schimmel L, Nawaz K, van Stalborch AM, de Haan A, Klaus-Bergmann A, Valent ET, Koenis DS, van Nieuw Amerongen GP, de Vries CJ, de Waard V, Gloerich M, van Buul JD, Huveneers S.

J Cell Sci. 2020 Feb 12;133(3). pii: jcs239947. doi: 10.1242/jcs.239947.

PMID:
31964713
4.

Volume incompliance and transfusion are essential for transfusion-associated circulatory overload: a novel animal model.

Klanderman RB, Bosboom JJ, Maas AAW, Roelofs JJTH, de Korte D, van Bruggen R, van Buul JD, Zuurbier CJ, Veelo DP, Hollmann MW, Vroom MB, Juffermans NP, Geerts BF, Vlaar APJ.

Transfusion. 2019 Dec;59(12):3617-3627. doi: 10.1111/trf.15565. Epub 2019 Nov 7.

5.

Nuclear shape, protrusive behaviour and in vivo retention of human bone marrow mesenchymal stromal cells is controlled by Lamin-A/C expression.

Dorland YL, Cornelissen AS, Kuijk C, Tol S, Hoogenboezem M, van Buul JD, Nolte MA, Voermans C, Huveneers S.

Sci Rep. 2019 Oct 7;9(1):14401. doi: 10.1038/s41598-019-50955-x.

6.

Human B Cells Engage the NCK/PI3K/RAC1 Axis to Internalize Large Particles via the IgM-BCR.

Verstegen NJM, Unger PA, Walker JZ, Nicolet BP, Jorritsma T, van Rijssel J, Spaapen RM, de Wit J, van Buul JD, Ten Brinke A, van Ham SM.

Front Immunol. 2019 Mar 13;10:415. doi: 10.3389/fimmu.2019.00415. eCollection 2019.

7.

CXCR4, but not CXCR3, drives CD8+ T-cell entry into and migration through the murine bone marrow.

Goedhart M, Gessel S, van der Voort R, Slot E, Lucas B, Gielen E, Hoogenboezem M, Rademakers T, Geerman S, van Buul JD, Huveneers S, Dolstra H, Anderson G, Voermans C, Nolte MA.

Eur J Immunol. 2019 Apr;49(4):576-589. doi: 10.1002/eji.201747438. Epub 2019 Feb 15.

8.

α1-Antichymotrypsin Present in Therapeutic C1-Inhibitor Products Competes with Selectin-Sialyl LewisX Interaction.

Engel R, Delvasto-Nuñez L, Roem D, van Mierlo G, Holst S, Hipgrave Ederveen AL, van Buul JD, Wuhrer M, Wouters D, Zeerleder S.

Thromb Haemost. 2018 Dec;118(12):2134-2144. doi: 10.1055/s-0038-1675601. Epub 2018 Nov 19.

PMID:
30453343
9.

Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 Adhesome.

Schimmel L, van der Stoel M, Rianna C, van Stalborch AM, de Ligt A, Hoogenboezem M, Tol S, van Rijssel J, Szulcek R, Bogaard HJ, Hofmann P, Boon R, Radmacher M, de Waard V, Huveneers S, van Buul JD.

Cell Rep. 2018 Sep 18;24(12):3115-3124. doi: 10.1016/j.celrep.2018.08.045.

10.

Role of glutamine synthetase in angiogenesis beyond glutamine synthesis.

Eelen G, Dubois C, Cantelmo AR, Goveia J, Brüning U, DeRan M, Jarugumilli G, van Rijssel J, Saladino G, Comitani F, Zecchin A, Rocha S, Chen R, Huang H, Vandekeere S, Kalucka J, Lange C, Morales-Rodriguez F, Cruys B, Treps L, Ramer L, Vinckier S, Brepoels K, Wyns S, Souffreau J, Schoonjans L, Lamers WH, Wu Y, Haustraete J, Hofkens J, Liekens S, Cubbon R, Ghesquière B, Dewerchin M, Gervasio FL, Li X, van Buul JD, Wu X, Carmeliet P.

Nature. 2018 Sep;561(7721):63-69. doi: 10.1038/s41586-018-0466-7. Epub 2018 Aug 29.

11.

Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells.

Goedhart M, Cornelissen AS, Kuijk C, Geerman S, Kleijer M, van Buul JD, Huveneers S, Raaijmakers MHGP, Young HA, Wolkers MC, Voermans C, Nolte MA.

Stem Cells Dev. 2018 May 1;27(9):579-589. doi: 10.1089/scd.2017.0196. Epub 2018 Apr 16.

12.

Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes.

Tang MW, Malvar Fernández B, Newsom SP, van Buul JD, Radstake TRDJ, Baeten DL, Tak PP, Reedquist KA, García S.

Rheumatology (Oxford). 2018 May 1;57(5):909-920. doi: 10.1093/rheumatology/kex511.

PMID:
29471421
13.

Inflammation-Sensitive Myosin-X Functionally Supports Leukocyte Extravasation by Cdc42-Mediated ICAM-1-Rich Endothelial Filopodia Formation.

Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M, van Alphen F, Hordijk P, Stroes ESG, Strömblad S, van Rheenen J, van Buul JD.

J Immunol. 2018 Mar 1;200(5):1790-1801. doi: 10.4049/jimmunol.1700702. Epub 2018 Jan 31.

14.

Endothelial RhoB and RhoC are dispensable for leukocyte diapedesis and for maintaining vascular integrity during diapedesis.

Schimmel L, de Ligt A, Tol S, de Waard V, van Buul JD.

Small GTPases. 2020 May;11(3):225-232. doi: 10.1080/21541248.2017.1377815. Epub 2018 Jan 29.

PMID:
28960175
15.

The role of endothelium in the onset of antibody-mediated TRALI.

Morsing KSH, Peters AL, van Buul JD, Vlaar APJ.

Blood Rev. 2018 Jan;32(1):1-7. doi: 10.1016/j.blre.2017.08.003. Epub 2017 Aug 5. Review.

PMID:
28823763
16.

Leukocyte Breaching of Endothelial Barriers: The Actin Link.

Alon R, van Buul JD.

Trends Immunol. 2017 Aug;38(8):606-615. doi: 10.1016/j.it.2017.05.002. Epub 2017 May 27. Review.

PMID:
28559148
17.

Flow-induced endothelial cell alignment requires the RhoGEF Trio as a scaffold protein to polarize active Rac1 distribution.

Kroon J, Heemskerk N, Kalsbeek MJT, de Waard V, van Rijssel J, van Buul JD.

Mol Biol Cell. 2017 Jul 1;28(13):1745-1753. doi: 10.1091/mbc.E16-06-0389. Epub 2017 May 17.

18.

Erratum to: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.

Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ES.

Arthritis Res Ther. 2016 Dec 13;18(1):298. No abstract available.

19.

Leukocyte transendothelial migration: A local affair.

Schimmel L, Heemskerk N, van Buul JD.

Small GTPases. 2017 Jan 2;8(1):1-15. doi: 10.1080/21541248.2016.1197872. Epub 2016 Aug 15. Review.

20.

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

van der Valk FM, Bekkering S, Kroon J, Yeang C, Van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LA, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, Stroes ES.

Circulation. 2016 Aug 23;134(8):611-24. doi: 10.1161/CIRCULATIONAHA.116.020838. Epub 2016 Aug 5.

21.

Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.

Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ES.

Arthritis Res Ther. 2016 May 21;18(1):115. doi: 10.1186/s13075-016-1008-z. Erratum in: Arthritis Res Ther. 2016 Dec 13;18(1):298.

22.

Recruitment of Immune Cells into Inflamed Tissues: Consequences for Endothelial Barrier Integrity and Tissue Functionality.

Schnoor M, Alcaide P, Voisin MB, van Buul JD.

Mediators Inflamm. 2016;2016:1561368. doi: 10.1155/2016/1561368. Epub 2016 Feb 17. No abstract available.

23.

Leukocytes Crossing the Endothelium: A Matter of Communication.

Timmerman I, Daniel AE, Kroon J, van Buul JD.

Int Rev Cell Mol Biol. 2016;322:281-329. doi: 10.1016/bs.ircmb.2015.10.005. Epub 2016 Jan 13.

PMID:
26940521
24.

Annexin A2 Limits Neutrophil Transendothelial Migration by Organizing the Spatial Distribution of ICAM-1.

Heemskerk N, Asimuddin M, Oort C, van Rijssel J, van Buul JD.

J Immunol. 2016 Mar 15;196(6):2767-78. doi: 10.4049/jimmunol.1501322. Epub 2016 Feb 10.

25.

Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions.

van Buul JD, Timmerman I.

Small GTPases. 2016;7(1):21-31. doi: 10.1080/21541248.2015.1131802. Epub 2016 Jan 29.

26.

F-actin-rich contractile endothelial pores prevent vascular leakage during leukocyte diapedesis through local RhoA signalling.

Heemskerk N, Schimmel L, Oort C, van Rijssel J, Yin T, Ma B, van Unen J, Pitter B, Huveneers S, Goedhart J, Wu Y, Montanez E, Woodfin A, van Buul JD.

Nat Commun. 2016 Jan 27;7:10493. doi: 10.1038/ncomms10493.

27.

Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin Trafficking.

Daniel AE, Timmerman I, Kovacevic I, Hordijk PL, Adriaanse L, Paatero I, Belting HG, van Buul JD.

PLoS One. 2015 Dec 29;10(12):e0145684. doi: 10.1371/journal.pone.0145684. eCollection 2015.

28.

Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells.

Lopes Pinheiro MA, Kroon J, Hoogenboezem M, Geerts D, van Het Hof B, van der Pol SM, van Buul JD, de Vries HE.

J Immunol. 2016 Jan 1;196(1):72-9. doi: 10.4049/jimmunol.1500702. Epub 2015 Nov 23.

29.

Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation.

Schnoor M, Alcaide P, Voisin MB, van Buul JD.

Mediators Inflamm. 2015;2015:946509. doi: 10.1155/2015/946509. Epub 2015 Oct 19. Review.

30.

A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.

Timmerman I, Heemskerk N, Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M, van Unen J, Goedhart J, Gadella TW Jr, Yin T, Wu Y, Huveneers S, van Buul JD.

J Cell Sci. 2015 Sep 15;128(18):3514. doi: 10.1242/jcs.179424. No abstract available.

31.

Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis.

Kooij G, Braster R, Koning JJ, Laan LC, van Vliet SJ, Los T, Eveleens AM, van der Pol SM, Förster-Waldl E, Boztug K, Belot A, Szilagyi K, van den Berg TK, van Buul JD, van Egmond M, de Vries HE, Cummings RD, Dijkstra CD, van Die I.

Acta Neuropathol Commun. 2015 Jul 25;3:45. doi: 10.1186/s40478-015-0223-1.

32.

Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.

van Strien ME, de Vries HE, Chrobok NL, Bol JGJM, Breve JJP, van der Pol SMP, Kooij G, van Buul JD, Karpuj M, Steinman L, Wilhelmus MM, Sestito C, Drukarch B, Van Dam AM.

Brain Behav Immun. 2015 Nov;50:141-154. doi: 10.1016/j.bbi.2015.06.023. Epub 2015 Jun 29.

PMID:
26133787
33.

A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.

Timmerman I, Heemskerk N, Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M, van Unen J, Goedhart J, Gadella TW Jr, Yin T, Wu Y, Huveneers S, van Buul JD.

J Cell Sci. 2015 Aug 15;128(16):3041-54. doi: 10.1242/jcs.168674. Epub 2015 Jun 26. Erratum in: J Cell Sci. 2015 Sep 15;128(18):3514.

34.

The Ins and Outs of Small GTPase Rac1 in the Vasculature.

Marinković G, Heemskerk N, van Buul JD, de Waard V.

J Pharmacol Exp Ther. 2015 Aug;354(2):91-102. doi: 10.1124/jpet.115.223610. Epub 2015 Jun 2. Review.

PMID:
26036474
35.

Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67phox.

Roos D, van Buul JD, Tool AT, Matute JD, Marchal CM, Hayee B, Köker MY, de Boer M, van Leeuwen K, Segal AW, Pick E, Dinauer MC.

J Clin Cell Immunol. 2014 Jun 30;5(3). pii: 1000231.

36.

A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.

Maiwald S, Motazacker MM, van Capelleveen JC, Sivapalaratnam S, van der Wal AC, van der Loos C, Kastelein JJ, Ouwehand WH, Hovingh GK, Trip MD, van Buul JD, Dallinga-Thie GM.

Eur J Hum Genet. 2016 Jan;24(1):86-91. doi: 10.1038/ejhg.2015.70. Epub 2015 Apr 22.

37.

In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans.

van der Valk FM, Kroon J, Potters WV, Thurlings RM, Bennink RJ, Verberne HJ, Nederveen AJ, Nieuwdorp M, Mulder WJ, Fayad ZA, van Buul JD, Stroes ES.

J Am Coll Cardiol. 2014 Sep 9;64(10):1019-29. doi: 10.1016/j.jacc.2014.06.1171.

38.

Real-time imaging of endothelial cell-cell junctions during neutrophil transmigration under physiological flow.

Kroon J, Daniel AE, Hoogenboezem M, van Buul JD.

J Vis Exp. 2014 Aug 14;(90):e51766. doi: 10.3791/51766.

39.

Actin-binding proteins differentially regulate endothelial cell stiffness, ICAM-1 function and neutrophil transmigration.

Schaefer A, Te Riet J, Ritz K, Hoogenboezem M, Anthony EC, Mul FP, de Vries CJ, Daemen MJ, Figdor CG, van Buul JD, Hordijk PL.

J Cell Sci. 2014 Oct 15;127(Pt 20):4470-82. doi: 10.1242/jcs.154708. Epub 2014 Aug 8. Erratum in: J Cell Sci. 2014 Nov 15;127(22):4985. J Cell Sci. 2014 Oct 15;127(Pt 20):doi/10.1242/jcs.164814.

40.

Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug.

Marinković G, Kroon J, Hoogenboezem M, Hoeben KA, Ruiter MS, Kurakula K, Otermin Rubio I, Vos M, de Vries CJ, van Buul JD, de Waard V.

J Immunol. 2014 May 1;192(9):4370-8. doi: 10.4049/jimmunol.1302527. Epub 2014 Mar 26.

41.

Sphingosine-1-phosphate receptor 3 mediates sphingosine-1-phosphate induced release of weibel-palade bodies from endothelial cells.

van Hooren KW, Spijkers LJ, van Breevoort D, Fernandez-Borja M, Bierings R, van Buul JD, Alewijnse AE, Peters SL, Voorberg J.

PLoS One. 2014 Mar 14;9(3):e91346. doi: 10.1371/journal.pone.0091346. eCollection 2014.

42.

Rho-GTPase signaling in leukocyte extravasation: an endothelial point of view.

Heemskerk N, van Rijssel J, van Buul JD.

Cell Adh Migr. 2014;8(2):67-75. Review.

43.

P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.

Kooij G, Kroon J, Paul D, Reijerkerk A, Geerts D, van der Pol SM, van Het Hof B, Drexhage JA, van Vliet SJ, Hekking LH, van Buul JD, Pachter JS, de Vries HE.

Acta Neuropathol. 2014 May;127(5):699-711. doi: 10.1007/s00401-014-1244-8. Epub 2014 Jan 16.

PMID:
24429546
44.

Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells.

Marinkovic G, Hibender S, Hoogenboezem M, van Broekhoven A, Girigorie AF, Bleeker N, Hamers AA, Stap J, van Buul JD, de Vries CJ, de Waard V.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2380-8. doi: 10.1161/ATVBAHA.113.301394. Epub 2013 Aug 15.

PMID:
23950142
45.

Endothelial cell preservation at hypothermic to normothermic conditions using clinical and experimental organ preservation solutions.

Post IC, de Boon WM, Heger M, van Wijk AC, Kroon J, van Buul JD, van Gulik TM.

Exp Cell Res. 2013 Oct 15;319(17):2501-13. doi: 10.1016/j.yexcr.2013.05.011. Epub 2013 Jun 20.

PMID:
23792081
46.

The Rho-GEF Trio regulates a novel pro-inflammatory pathway through the transcription factor Ets2.

Van Rijssel J, Timmerman I, Van Alphen FP, Hoogenboezem M, Korchynskyi O, Geerts D, Geissler J, Reedquist KA, Niessen HW, Van Buul JD.

Biol Open. 2013 Apr 16;2(6):569-79. doi: 10.1242/bio.20134382. Print 2013 Jun 15.

47.

Endothelial junction regulation: a prerequisite for leukocytes crossing the vessel wall.

Daniel AE, van Buul JD.

J Innate Immun. 2013;5(4):324-35. doi: 10.1159/000348828. Epub 2013 Apr 3. Review.

48.

Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55.

Karpus ON, Veninga H, Hoek RM, Flierman D, van Buul JD, Vandenakker CC, vanBavel E, Medof ME, van Lier RA, Reedquist KA, Hamann J.

J Immunol. 2013 Apr 1;190(7):3740-8. doi: 10.4049/jimmunol.1202192. Epub 2013 Feb 27.

49.

The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis.

Samson T, van Buul JD, Kroon J, Welch C, Bakker EN, Matlung HL, van den Berg TK, Sharek L, Doerschuk C, Hahn K, Burridge K.

PLoS One. 2013;8(1):e55202. doi: 10.1371/journal.pone.0055202. Epub 2013 Jan 25.

50.

Rho GAPs and GEFs: controling switches in endothelial cell adhesion.

van Buul JD, Geerts D, Huveneers S.

Cell Adh Migr. 2014;8(2):108-24. Review.

Supplemental Content

Loading ...
Support Center